The 3 most recent market catalysts affecting $PIII, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 10, 2026
Corporate Catalyst
Bullish
Impact 65
12 Health Care Stocks Moving In Monday's After-Market Session
This filing highlights the immediate market reaction to Q2 earnings reports for a selection of healthcare companies. The significant after-market movements, both positive and negat…
Aug 10, 2026
Corporate Catalyst
Bullish
Impact 75
P3 Health Partners Q2 EPS $(0.63) Beats $(1.90) Estimate, Sales $386.381M Beat $377.950M Estimate
P3 Health Partners' substantial beat on both EPS and sales indicates better-than-expected performance, likely driven by successful patient engagement and cost management strategies…
Aug 10, 2026
Corporate Catalyst
Bearish
Impact 75
P3 Health Partners Narrows FY2026 Sales Guidance from $1.500B-$1.650B to $1.500B-$1.600B vs $1.524B Est
P3 Health Partners (PIII) has updated its FY2026 sales outlook, reducing the upper bound of its guidance from $1.650 billion to $1.600 billion, while maintaining the lower bound at…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.